{"corpus_id":23228546,"paper_sha":"5a4ca8961a7e9b67bf6a95ef663efdabab20675b","doi":"10.1016/S0749-0704(05)70293-1","arxiv_id":null,"pmid":9012573,"pmcid":null,"mag_id":2019411410,"dblp_id":null,"acl_id":null,"title":"Guillain-Barré syndrome.","year":2019,"publication_date":"2019-07-01","venue":"Critical care clinics","journal":{"name":"Critical care clinics","pages":"\n          1-15\n        ","volume":"13 1"},"journal_issn":null,"journal_title":null,"publication_types":["Review","JournalArticle"],"pubmed_pub_types":["Journal Article","Review"],"s2_fields_of_study":["Medicine"],"reference_count":54,"citation_count":31,"influential_citation_count":1,"is_open_access":false,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Critical Care","mj":true,"ui":"D003422"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Intensive Care Units","mj":false,"ui":"D007362"},{"d":"Polyradiculoneuropathy","mj":false,"qs":[{"q":"mortality","mj":false,"ui":"Q000401"},{"q":"physiopathology","mj":true,"ui":"Q000503"},{"q":"therapy","mj":true,"ui":"Q000628"}],"ui":"D011129"}],"chemicals":null,"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":null,"s2_open_access_landing_url":null,"s2_open_access_license":null,"s2_open_access_status":null,"pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"The leading cause of acute neuromuscular weakness in the developed world is Guillain-Barré syndrome (GBS). Mortality rates vary widely. This article discusses the care and management of patients with GBS, with an emphasis on those patients who require admission to an intensive care unit.","claims":[{"public_id":"cl_d02a71cdb2409542633b051a2e5af75e","status":"active","text":"Care and management of patients with Guillain-Barré syndrome are discussed with emphasis on patients who require admission to an intensive care unit.","confidence":0.94,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_d02a71cdb2409542633b051a2e5af75e"},{"public_id":"cl_a0839f5abd20d0d6e192097c1aae70c1","status":"active","text":"Mortality rates in Guillain-Barré syndrome vary widely.","confidence":0.97,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_a0839f5abd20d0d6e192097c1aae70c1"}],"concepts":[{"public_id":"co_62aa2999993ea1105698c2eb0879a70b","status":"active","name":"intensive care unit","description":"A hospital unit that provides close monitoring and advanced life support for critically ill patients.","types":["clinical setting"],"aliases":["ICU"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_62aa2999993ea1105698c2eb0879a70b"},{"public_id":"co_6456d2cc087d8945885507b79a0b77e5","status":"active","name":"Guillain-Barré syndrome","description":"An acute neuromuscular disorder characterized by rapidly developing weakness.","types":["condition"],"aliases":["GBS"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_6456d2cc087d8945885507b79a0b77e5"},{"public_id":"co_bac8c1710ff87350b07f14d401168799","status":"active","name":"care and management","description":"Clinical approaches used to monitor, support, and treat patients with a condition.","types":["clinical management"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_bac8c1710ff87350b07f14d401168799"},{"public_id":"co_e243c71d7b1379050dc3f149d96a5bea","status":"active","name":"mortality rates","description":"The proportion of deaths among patients with a condition or in a study population.","types":["outcome"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_e243c71d7b1379050dc3f149d96a5bea"}],"external_ids":{"DOI":"10.1016/S0749-0704(05)70293-1","ArXiv":null,"PubMed":9012573,"PubMedCentral":null,"MAG":2019411410,"DBLP":null,"ACL":null},"open_access":{"is_open_access":false,"pdf_url":null,"landing_url":"https://sah.borca.ai/papers/23228546","source":null,"pdf_url_source":null,"license":null,"reason":"pdf_url_not_indexed"},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":638864,"paper_uid":"8766c650-4b37-49a1-a004-688850f46bf4","canonical_identity":{"paper_id":638864,"paper_uid":"8766c650-4b37-49a1-a004-688850f46bf4","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/23228546"}